Ewelina Mamcarz

Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1

Ewelina Mamcarz, Sheng Zhou, Timothy Lockey et al. · New England Journal of Medicine · 2019 · 258 citations · Full text

Selective T‐cell depletion targeting <scp>CD</scp>45<scp>RA</scp> reduces viremia and enhances early T‐cell recovery compared with <scp>CD</scp>3‐targeted T‐cell depletion

Brandon M. Triplett, Brad Muller, Guolian Kang et al. · Transplant Infectious Disease · 2017 · 64 citations · Full text

Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL

Aimee C. Talleur, Amr Qudeimat, Jean‐Yves Métais et al. · Blood Advances · 2022 · 55 citations · Full text

Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony–Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells

Aimee C. Talleur, Brandon M. Triplett, Sara M. Federico et al. · Biology of Blood and Marrow Transplantation · 2017 · 47 citations · Full text

Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution

Ewelina Mamcarz, Renee Madden, Amr Qudeimat et al. · Bone Marrow Transplantation · 2019 · 42 citations · Full text

Last 15, Cell Therapy, Transplantation +11